Article info

Download PDFPDF
CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors
  1. Correspondence to:
 C Monteagudo
 Departamento de Patología, Facultad de Medicina, Avda Blasco Ibanez 15, 46010 Valencia, Spain; Carlos.Monteagudo{at}uv.es
View Full Text

Citation

Monteagudo C, Martin JM, Jorda E, et al
CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors

Publication history

  • Accepted October 13, 2005
  • First published March 7, 2006.
Online issue publication 
June 08, 2007

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.